{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:08:53Z","timestamp":1762898933282},"reference-count":52,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.05.097","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T00:30:50Z","timestamp":1370997050000},"page":"3473-3484","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012"],"prefix":"10.1016","volume":"31","author":[{"given":"Isabel","family":"Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"P\u00e9rez-Camarero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"del Llano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz Mar\u00eda","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Hidalgo-Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.05.097_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1576-9887(11)70002-4","article-title":"Evidencias cient\u00edficas disponibles sobre la seguridad de las vacunas","volume":"12","author":"Picazo","year":"2011","journal-title":"Vacunas"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1377\/hlthaff.24.3.611","article-title":"The history of vaccines and immunization: familiar patterns, new challenges","volume":"24","author":"Stern","year":"2005","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0015","unstructured":"Vacunas.org. Historia de las vacunas. http:\/\/www.vacunas.org\/es\/info-publico\/historia-de-las-vacunas; 2010."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0020","series-title":"Vaccines","author":"Plotkin","year":"2008"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0025","series-title":"Biotechnology","author":"David","year":"2010"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0030","series-title":"Vacunas de nueva generaci\u00f3n. Informe de vigilancia tecnol\u00f3gica","year":"2004"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0035","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1098\/rstb.2011.0076","article-title":"Vaccines and global health","volume":"366","author":"Greenwood","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0040","unstructured":"UNICEF. Expanding immunization coverage. http:\/\/www.unicef.org\/immunization\/index_coverage.html; 2012."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0045","unstructured":"WHO. Immunization service delivery. http:\/\/www.who.int\/immunization_delivery\/en\/; 2012."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0050","series-title":"Disease control priorities in developing countries","author":"Brenzel","year":"2006"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0055","unstructured":"Epidemiolog\u00eda. SEd Epidemilog\u00eda de las enfermedades incluidas en un programa de vacunaci\u00f3n; 2004."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0060","unstructured":"Igualdad. MdSPSe. Prevenci\u00f3n y promoci\u00f3n. Programa de vacunaci\u00f3n. http:\/\/www.msps.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/vacunasProfesionales.htm; 2011."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0065","unstructured":"Farmaindustria F. La aportaci\u00f3n de las vacunas a la salud. El valor del medicamneto. Journal 2003."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1157\/13073419","article-title":"Impacto de los programas de vacunaci\u00f3n en Espa\u00f1a","volume":"35","author":"Pachon","year":"2005","journal-title":"Aten Primaria"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0075","unstructured":"WHO. Vaccine preventable diseases monitoring system. Immunization schedules by antigen. http:\/\/apps.who.int\/immunization_monitoring\/en\/globalsummary\/scheduleselect.cfm; 2011."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0080","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.gaceta.2009.07.011","article-title":"Propuesta de gu\u00eda para la evaluaci\u00f3n econ\u00f3mica aplicada a las tecnolog\u00edas sanitarias","volume":"24","author":"L\u00f3pez Bastida","year":"2010","journal-title":"Gac Sanit"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0090","unstructured":"Quir\u00f3s AB. Clasificaci\u00f3n de las vacunas. http:\/\/vacunasaep.org\/manual\/Cap3_4_Clasificacion_vacunas.pdf; 2008."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0095","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.vaccine.2007.04.070","article-title":"Do we fully understand the economic value of vaccines?","volume":"25","author":"Drummond","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0100","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1016\/j.vaccine.2005.12.043","article-title":"Vaccinating healthcare workers against influenza to protect the vulnerable \u2013 is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation","volume":"24","author":"Burls","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00019053-200826010-00003","article-title":"Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies","volume":"26","author":"Anonychuk","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0110","first-page":"264","article-title":"Economic analyses of rubella and rubella vaccines: a global review","volume":"80","author":"Hinman","year":"2002","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1586\/erv.11.197","article-title":"A review of the literature on the economics of vaccination against TB","volume":"11","author":"Tu","year":"2012","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0120","first-page":"54","article-title":"Coste-beneficio de la vacuna de la varicela. Revisi\u00f3n sistem\u00e1tica","volume":"59","author":"D\u00edez-Domingo","year":"2003","journal-title":"An Pediatr"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1586\/14737167.5.5.541","article-title":"Pneumococcal polysaccharide vaccine: cost-effectiveness recommendations in adults","volume":"5","author":"Plans-Rubi\u00f3","year":"2005","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ypmed.2009.02.011","article-title":"Economic evaluations of massive HPV vaccination: within-study and between study variations in incremental cost per QALY gained","volume":"48","author":"Puig-Junoy","year":"2009","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0135","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2004.03.048","article-title":"Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain","volume":"22","author":"Plans-Rubio","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0140","first-page":"25","article-title":"Evoluci\u00f3n y caracter\u00edsticas de los brotes de hepatitis A en Catalu\u00f1a","volume":"1","author":"Mart\u00ednez","year":"2011","journal-title":"Newsl Hepat A Epidemiolog\u00eda"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0145","unstructured":"Criterios para fundamentar la modificaci\u00f3n de los programas de vacuna. Ministerio de Sanidad y Consumo, Direcci\u00f3n General de Salud P\u00fablica, Subdirecci\u00f3n General de Promoci\u00f3n de la Salud y Epidemiolog\u00eda; 2004."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0150","first-page":"26","article-title":"Vacuna neumoc\u00f3cica. El final de la cuenta atr\u00e1s","author":"Garc\u00eda-P\u00e9rez","year":"2001","journal-title":"BSCP Can Ped"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0155","unstructured":"Consumo. MdSy: Notas de Prensa El Ministerio de Sanidad y Consumo decide continuar con el procedimiento para la comercializaci\u00f3n de la vacuna frente al virus del papiloma humano (Gardasil). 2007."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0160","first-page":"2","article-title":"Vacunaci\u00f3n antidift\u00e9rica","volume":"11","author":"Salleras","year":"2010","journal-title":"Vacunas"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0165","first-page":"24","article-title":"Vacunaci\u00f3n contra la tos ferina","volume":"11","author":"Salleras","year":"2010","journal-title":"Vacunas"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0170","first-page":"74","article-title":"Vacunaci\u00f3n contra el sarampi\u00f3n, la rub\u00e9ola y la parotiditis","volume":"11","author":"Dom\u00ednguez","year":"2010","journal-title":"Vacunas"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1099-1050(199805)7:3<221::AID-HEC341>3.0.CO;2-N","article-title":"Use of economic evaluation guidelines: 2 years\u2019 experience in Canada","volume":"7","author":"Baladi","year":"1998","journal-title":"Health Econ"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hec.4730030206","article-title":"Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis","volume":"3","author":"Briggs","year":"1994","journal-title":"Health Econ"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0185","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/009286159603000417","article-title":"Review of health economic guidelines in the form of regulations, principles, policies, and positions","volume":"30","author":"Genduso","year":"1996","journal-title":"Drugs Inform J"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0190","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0213-9111(00)71915-7","article-title":"La declaraci\u00f3n del conflicto de intereses en las publicaciones cient\u00edficas. \u00bfTiempo para las luces y los taqu\u00edgrafos en la trastienda de la investigaci\u00f3n financiada por la industria?","volume":"14","author":"Peir\u00f3","year":"2000","journal-title":"Gac Sanit"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0195","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM200002243420812","article-title":"Disclosure of authors\u2019 conflicts of interest: a follow-up","volume":"342","author":"Angell","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0200","unstructured":"Puig-Junoy J, Pinto JL. El coste de oportunidad del tiempo remunrado en la producci\u00f3n de salud. Documento de trabajo de la Fundaci\u00f3n BBVA, 2001."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00019053-200826010-00005","article-title":"Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination","volume":"26","author":"Pradas-Velasco","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0210","first-page":"33","article-title":"Vacunaci\u00f3n contra la hepatitis B","volume":"11","author":"Salleras","year":"2010","journal-title":"Vacunas"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0215","first-page":"39","article-title":"Vacunaci\u00f3n contra la hepatitis A en la adolescencia y edad adulta joven","volume":"11","author":"Salleras","year":"2010","journal-title":"Vacunas"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0220","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1576-9887(10)70014-5","article-title":"Vacunaci\u00f3n antineumoc\u00f3cica polisac\u00e1rida 23-valente","volume":"11","author":"Salleras","year":"2010","journal-title":"Vacunas"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0225","first-page":"56","article-title":"Vacunaci\u00f3n antivaricela para adolescentes y adultos","volume":"11","author":"Salleras","year":"2010","journal-title":"Vacunas"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0230","first-page":"9","article-title":"Vacunaci\u00f3n antitet\u00e1nica","volume":"11","author":"Dom\u00ednguez","year":"2010","journal-title":"Vacunas"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0235","unstructured":"Ministerio d, Sanidad, Pol\u00edtica, Social, e, Igualdad.: Prevenci\u00f3n y promoci\u00f3n. Programa de vacunaci\u00f3n. In: Ministerio de Sanidad PSeI (ed) 2008."},{"key":"10.1016\/j.vaccine.2013.05.097_bib0240","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/INF.0b013e318165f1ba","article-title":"Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia","volume":"27","author":"Gessner","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0245","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/j.vaccine.2006.05.032","article-title":"The cost-effectiveness of alternative polio immunization policies in South Africa","volume":"24","author":"Griffiths","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0250","first-page":"50","article-title":"Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India","volume":"28","author":"Gupta","year":"2012","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0255","first-page":"192","article-title":"Impacto de los estudios de evaluaci\u00f3n econ\u00f3mica en la toma de decisiones sanitarias en Atenci\u00f3n Primaria","volume":"7","author":"Oliva","year":"2001","journal-title":"Cuadernos de Gesti\u00f3n"},{"key":"10.1016\/j.vaccine.2013.05.097_bib0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2013.01.029","article-title":"Systematic review of economic evaluation studies: are vaccination programs efficient in Spain?","author":"Garc\u00eda-Alt\u00e9s","year":"2013","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13007251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13007251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T05:55:13Z","timestamp":1563170113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13007251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":52,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13007251"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.097","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}